Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials

Ian N Bruce; Richard A Furie; Eric F Morand; Susan Manzi; Yoshiya Tanaka; Kenneth C. Kalunian; Joan T Merrill; Patricia Puzio; Emmanuelle Maho; Christi Kleoudis; Marius Albulescu; Micki Hultquist; Raj Tummala

doi:10.1136/annrheumdis-2021-221847

Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials

Ian N Bruce, Richard A Furie, Eric F Morand, Susan Manzi, Yoshiya Tanaka, Kenneth C. Kalunian, Joan T Merrill, Patricia Puzio, Emmanuelle Maho, Christi Kleoudis, Marius Albulescu, Micki Hultquist, Raj Tummala

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Annals of the rheumatic diseases
DOIs	https://doi.org/10.1136/annrheumdis-2021-221847
Publication status	Published - Jul 2022

Access to Document

10.1136/annrheumdis-2021-221847

Cite this

Bruce, I. N., Furie, R. A., Morand, E. F., Manzi, S., Tanaka, Y., Kalunian, K. C., Merrill, J. T., Puzio, P., Maho, E., Kleoudis, C., Albulescu, M., Hultquist, M., & Tummala, R. (2022). Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials. Annals of the rheumatic diseases. https://doi.org/10.1136/annrheumdis-2021-221847

@article{2427488ad3414e0788f1849f5eaf1a43,

title = "Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials",

author = "Bruce, {Ian N} and Furie, {Richard A} and Morand, {Eric F} and Susan Manzi and Yoshiya Tanaka and Kalunian, {Kenneth C.} and Merrill, {Joan T} and Patricia Puzio and Emmanuelle Maho and Christi Kleoudis and Marius Albulescu and Micki Hultquist and Raj Tummala",

year = "2022",

month = jul,

doi = "10.1136/annrheumdis-2021-221847",

language = "English",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials

AU - Bruce, Ian N

AU - Furie, Richard A

AU - Morand, Eric F

AU - Manzi, Susan

AU - Tanaka, Yoshiya

AU - Kalunian, Kenneth C.

AU - Merrill, Joan T

AU - Puzio, Patricia

AU - Maho, Emmanuelle

AU - Kleoudis, Christi

AU - Albulescu, Marius

AU - Hultquist, Micki

AU - Tummala, Raj

PY - 2022/7

Y1 - 2022/7

UR - https://doi.org/10.1136/annrheumdis-2021-221847

U2 - 10.1136/annrheumdis-2021-221847

DO - 10.1136/annrheumdis-2021-221847

M3 - Article

SN - 0003-4967

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

ER -

Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials

Access to Document

Other files and links

Cite this